Schroder Investment Management Group Aurinia Pharmaceuticals Inc. Transaction History
Schroder Investment Management Group
- $122 Billion
- Q3 2025
A detailed history of Schroder Investment Management Group transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 218,743 shares of AUPH stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
218,743
Previous 547,802
60.07%
Holding current value
$3.36 Million
Previous $4.64 Million
47.9%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUPH
# of Institutions
267Shares Held
69.5MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$142 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.8 Million0.03% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...